Amcor said it filed the definitive joint proxy statement with the SEC with Berry Global Group, Inc. on January 23, 2025. The shareholder meetings of both companies will both be held on February 25, 2025.

1. 01

   Amcor said it filed the definitive joint proxy statement with the SEC with Berry Global Group, Inc. on January 23, 2025. The shareholder meetings of both companies will both be held on February 25, 2025.

2. 02

   Amcor said the all-stock transaction with Berry would create a global leader in consumer and healthcare packaging. The transaction was unanimously recommended by both companies' boards, and the company said completion is expected in the middle of calendar 2025.

3. 03

   The company said identified cost, growth and financial synergies of about $650 million are to be achieved by the end of the 3rd year after completion of the transaction. This includes annual run-rate pre-tax cost synergies of about $530 million, financial savings of about $60 million, and an annual run-rate pre-tax earnings benefit from growth synergies of about $60 million.

4. 04

   Amcor said it expects combined annual cash flow to exceed $3 billion and adjusted cash earnings per share accretion to exceed 35%. The accretion figure includes the run-rate impact of synergies by the end of the 3rd year after completion and is measured against Amcor's standalone EPS for the LTM period ended September 30, 2024.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.